Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-08-15

FDA Approved: MILOPHENE — Supplemental Application (Burel Pharmaceuticals, LLC)

View source ↗

Summary

FDA lists a supplemental application for MILOPHENE (clomiphene citrate) from Burel Pharmaceuticals, LLC. The submission pertains to an update to the product's a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MILOPHENE (CLOMIPHENE CITRATE)

Snippet

SUPPL AP for MILOPHENE (CLOMIPHENE CITRATE)